-+ 0.00%
-+ 0.00%
-+ 0.00%

LIGAND PHARMACEUTICALS INCORPORATED : RBC RAISES TARGET PRICE TO $357 FROM $345

Reuters·10/30/2026 03:33:04

Please log in to view news